Home > Insider Trading > Filing (0001209191-12-035538)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
858803	Avanir Pharmaceuticals Inc.	AVNR	Pharmaceutical Preparations (2834)	330314804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314596	Keith Katkin	20 Enterprise, Suite 200 Aliso Viejo CA 92656	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-06-25	190,125	$3.50	137,732	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
This sale of shares of common stock was a "matching" transaction under Section 16(b) of the Securities Exchange Act of 1934, as amended, withrespect to 10,000 of such shares, with the reporting person's purchase of 10,000 shares of the issuer's common stock on March 6, 2012. Uponsettlement of the sale, the reporting person will disgorge to the issuer the full amount of the profit realized in connection with such short swingtransaction, less transaction costs.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.47 to $3.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.